Literature DB >> 17000761

The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.

Alexander Schepsky1, Katja Bruser, Gunnar J Gunnarsson, Jane Goodall, Jón H Hallsson, Colin R Goding, Eirikur Steingrimsson, Andreas Hecht.   

Abstract

Commitment to the melanocyte lineage is characterized by the onset of expression of the microphthalmia-associated transcription factor (Mitf). This transcription factor plays a fundamental role in melanocyte development and maintenance and seems to be crucial for the survival of malignant melanocytes. Furthermore, Mitf has been shown to be involved in cell cycle regulation and to play important functions in self-renewal and maintenance of melanocyte stem cells. Although little is known about how Mitf regulates these various processes, one possibility is that Mitf interacts with other regulators. Here we show that Mitf can interact directly with beta-catenin, the key mediator of the canonical Wnt signaling pathway. The Wnt signaling pathway plays a critical role in melanocyte development and is intimately involved in triggering melanocyte stem cell proliferation. Significantly, constitutive activation of this pathway is a feature of a number of cancers including malignant melanoma. Here we show that Mitf can redirect beta-catenin transcriptional activity away from canonical Wnt signaling-regulated genes toward Mitf-specific target promoters to activate transcription. Thus, by a feedback mechanism, Mitf can diversify the output of canonical Wnt signaling to enhance the repertoire of genes regulated by beta-catenin. Our results reveal a novel mechanism by which Wnt signaling and beta-catenin activate gene expression, with significant implications for our understanding of both melanocyte development and melanoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000761      PMCID: PMC1636837          DOI: 10.1128/MCB.02299-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway.

Authors:  R I Dorsky; D W Raible; R T Moon
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

2.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Authors:  M Wu; T J Hemesath; C M Takemoto; M A Horstmann; A G Wells; E R Price; D Z Fisher; D E Fisher
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

3.  Pax3 functions at a nodal point in melanocyte stem cell differentiation.

Authors:  Deborah Lang; Min Min Lu; Li Huang; Kurt A Engleka; Maozhen Zhang; Emily Y Chu; Shari Lipner; Arthur Skoultchi; Sarah E Millar; Jonathan A Epstein
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

4.  Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination.

Authors:  Lorin E Olson; Jessica Tollkuhn; Claudio Scafoglio; Anna Krones; Jie Zhang; Kenneth A Ohgi; Wei Wu; Makoto M Taketo; Rolf Kemler; Rudolf Grosschedl; Dave Rose; Xue Li; Michael G Rosenfeld
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

5.  Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche.

Authors:  Emi K Nishimura; Scott R Granter; David E Fisher
Journal:  Science       Date:  2004-12-23       Impact factor: 47.728

6.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

7.  Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.

Authors:  Keith W Vance; Suzanne Carreira; Gerald Brosch; Colin R Goding
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

8.  Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes.

Authors:  Denise J Schwahn; Nikolai A Timchenko; Shigeki Shibahara; Estela E Medrano
Journal:  Pigment Cell Res       Date:  2005-06

9.  Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways.

Authors:  V Easwaran; M Pishvaian; S Byers
Journal:  Curr Biol       Date:  1999-12-02       Impact factor: 10.834

10.  MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.

Authors:  Amy E Loercher; Elizabeth M H Tank; Rachel B Delston; J William Harbour
Journal:  J Cell Biol       Date:  2004-12-28       Impact factor: 10.539

View more
  67 in total

1.  Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.

Authors:  S J Gallagher; F Rambow; M Kumasaka; D Champeval; A Bellacosa; V Delmas; L Larue
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

Review 2.  Regulation of melanocyte stem cells in the pigmentation of skin and its appendages: Biological patterning and therapeutic potentials.

Authors:  Weiming Qiu; Cheng-Ming Chuong; Mingxing Lei
Journal:  Exp Dermatol       Date:  2019-01-15       Impact factor: 3.960

3.  p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.

Authors:  Cheong-Yong Yun; Soon-Tae You; Jin-Hwa Kim; Jin H Chung; Sang-Bae Han; Eun-Young Shin; Eung-Gook Kim
Journal:  J Invest Dermatol       Date:  2015-01-05       Impact factor: 8.551

Review 4.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

5.  Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.

Authors:  Deeba N Syed; Farrukh Afaq; Nityanand Maddodi; Jeremy J Johnson; Sami Sarfaraz; Adeel Ahmad; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  J Invest Dermatol       Date:  2011-02-24       Impact factor: 8.551

6.  Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.

Authors:  William D Tap; Ke-Wei Gong; Judy Dering; Yiou Tseng; Charles Ginther; Giovanni Pauletti; John A Glaspy; Richard Essner; Gideon Bollag; Peter Hirth; Chao Zhang; Dennis J Slamon
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 7.  Molecular and cellular pathogenesis of melanoma initiation and progression.

Authors:  Tarik Regad
Journal:  Cell Mol Life Sci       Date:  2013-03-27       Impact factor: 9.261

Review 8.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

Review 9.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

Review 10.  Emerging phytochemicals for prevention of melanoma invasion.

Authors:  Virginia Jones; Santosh K Katiyar
Journal:  Cancer Lett       Date:  2013-03-06       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.